Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Parkville
Clinical trial register · Australia

Clinical Trials in Parkville, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3370 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:19 UTC
3370
Studies in scope
all four open statuses
1816
Recruiting now
open to new participants
776
Lead sponsors
across recruiting studies
Top sites
Melbourne 1109 Adelaide 582 Sydney 520 Westmead 421 Clayton 411
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Murdoch Childrens Research Institute17 Hoffmann-La Roche17 Children's Oncology Group16 BioMarin Pharmaceutical11 Novartis Pharmaceuticals11 Pfizer8 National Cancer Institute (NCI)8 Janssen Research & Development, LLC8 AstraZeneca7 Sanofi6 Eli Lilly and Company5 University of Melbourne5 Alexion Pharmaceuticals, Inc.5 Boehringer Ingelheim5 QED Therapeutics, a BridgeBio company5 Takeda5 AbbVie5 Vertex Pharmaceuticals Incorporated4 argenx3 Biogen3 Biohaven Therapeutics Ltd.3 Genentech, Inc.3 Bayer3 Novo Nordisk A/S3 Merck Sharp & Dohme LLC3 Show all 149
Site location
Melbourne1109 Adelaide582 Sydney520 Westmead421 Clayton411 Nedlands381 Brisbane355 Camperdown348 Parkville320 South Brisbane313 Perth299 Heidelberg273 Darlinghurst246 Woolloongabba239 Randwick210 St Leonards198 Liverpool195 Murdoch188 Fitzroy176 Kogarah162 Box Hill157 Southport154 Bedford Park154 Wollongong149 Herston143 Show all 396
All 396 locations
Target enrolment
to

Trials with a site in Parkville

320 of 3370 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Speed of Lung Inflation During Ventilation of Extremely Preterm Infants
NCT07101419Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant
Murdoch Childrens Research Institute
Not applicable
68
Heidelberg, Parkville, Saint Albans
2027-02
Not yet open
Perceptions and Acceptance of Grafting of Cryopreserved Testicular Tissue
NCT07915375Fertility, Testicular Tissue Cryopreserved, Fertility Preservation
Murdoch Childrens Research Institute
Observational
105
Parkville
2026-12-01
Recruiting
Hoffmann-La Roche
Phase 2
450
Camperdown, Parkville
2026-11-15
Recruiting
Genentech, Inc.
Phase 1
46
Parkville
2026-11-02
Recruiting
Biomed Industries, Inc.
Phase 3
210
Camperdown, South Brisbane, Heidelberg West, Parkville
2026-09-30
Recruiting
A Study in Adults With Geographic Atrophy
NCT07606365Geographic Atrophy
DrugSTL303
Sitala Bio LTD
Phase 2
300
Sydney, Westmead, South Brisbane, Adelaide, East Melbourne, Parkville
2026-09-11
Recruiting
Murdoch Childrens Research Institute
Not applicable
10
Parkville
2026-09
Recruiting
AstraZeneca
Phase 2
24
Nedlands, Parkville, Southport, Westmead
2026-08-31
Recruiting
Hoffmann-La Roche
Phase 3
100
South Brisbane, Parkville, Nedlands
2026-08-18
Recruiting
iVEAcare
Not applicable
30
Herston, South Brisbane, Clayton, Fitzroy, Heidelberg, Melbourne, Parkville
2026-07-29
Recruiting
Novartis Pharmaceuticals
Phase 3
710
Sydney, Melbourne, Parkville
2026-07-10
Recruiting
AstraZeneca
Phase 3
600
Campbelltown, East Toowoomba, Heidelberg Heights, Parkville, St Leonards
2026-07-08
Recruiting
AstraZeneca
Phase 3
1,200
Botany, East Toowoomba, Fitzroy, Heidelberg Heights, Kingswood, Melbourne, Parkville, Penrith
2026-07-06
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
134
Randwick, Parkville
2026-07-06
Recruiting
Genentech, Inc.
Phase 1
160
Parkville
2026-06-23
Recruiting
DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
NCT07623525Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension
Diagonal Therapeutics, Inc.
Phase 1/2
93
Camperdown, Randwick, Herston, East Melbourne, Parkville, West Perth
2026-06-04
Not yet open
Queensland Centre for Gynaecological Cancer
Phase 3
640
Newcastle, Darwin, Auchenflower, Brisbane, Buderim, Adelaide, Heidelberg, Parkville
2026-06-01
Recruiting
TAG TEAM - Trans Adolescent Group Therapy
NCT07151079Minority Stress, Acceptability, Psychological Distress, Anxiety
Murdoch Childrens Research Institute
Not applicable
142
Parkville
2026-05-21
Recruiting
Lumos Pharma
Phase 3
150
South Brisbane, Clayton, Parkville
2026-05-20
Recruiting
Jade Biosciences, Inc.
Phase 2
30
Concord, Liverpool, Parkville
2026-05-19
Recruiting
Sarepta Therapeutics, Inc.
Phase 1
32
Westmead, Parkville
2026-05-12
Recruiting
Pfizer
Phase 3
2,400
Westmead, Brisbane, South Brisbane, Clayton, Parkville, Nedlands
2026-05-04
Recruiting
Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study
NCT07251790Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant
Murdoch Childrens Research Institute
Not applicable
134
Melbourne, Parkville, Saint Albans
2026-05-04
Recruiting
Hoffmann-La Roche
Phase 3
360
Camperdown, Melbourne, Parkville
2026-04-27
By invitation
QED Therapeutics, a BridgeBio company
Phase 2
135
Parkville
2026-04-23
Recruiting
BioMarin Pharmaceutical
Phase 2/3
160
Parkville
2026-04-20
Recruiting
Hoffmann-La Roche
Phase 3
100
South Brisbane, Parkville, Nedlands
2026-04-15
By invitation
Skyhawk Therapeutics, Inc.
Phase 2/3
500
New Lambton Heights, Westmead, Herston, Adelaide, Caulfield South, Parkville, Nedlands
2026-04-10
Recruiting
Medtronic Cardiac Ablation Solutions
Not applicable
400
Westmead, Adelaide, Parkville
2026-04-08
Recruiting
Bristol-Myers Squibb
Phase 1/2
198
Camperdown, Westmead, Birtinya, Parkville
2026-03-16
Recruiting
Sanofi
Phase 2/3
526
Sydney, Adelaide, Clayton, Parkville
2026-03-13
Recruiting
Boehringer Ingelheim
Phase 3
1,325
Campbelltown, Liverpool, New Lambton Heights, Adelaide, Box Hill, Clayton, Parkville
2026-02-17
Recruiting
Boehringer Ingelheim
Phase 3
286
Concord, Kingswood, Kogarah, Westmead, Herston, Southport, Adelaide, Parkville
2026-02-16
Recruiting
Eli Lilly and Company
Phase 3
300
Adelaide, Heidelberg West, Ipswich, Melbourne, Oaklands Park, Parkville, Perth, Randwick
2026-02-05
Not yet open
St Vincent's Hospital Melbourne
Phase 2
115
Fitzroy, Heidelberg, Melbourne, Parkville
2026-02
Recruiting
Murdoch Childrens Research Institute
Observational
147
Parkville
2026-01-13
Recruiting
Eli Lilly and Company
Phase 3
150
Adelaide, Box Hill, Brisbane, Melbourne, Parkville, Perth, Randwick, Westmead
2026-01-12
Recruiting
Biogen
Phase 2
81
Westmead, Brisbane, Parkville, Murdoch
2026-01-05
Recruiting
argenx
Phase 2
60
Randwick, Parkville
2025-12-19
Recruiting
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
NCT07194070Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC
Observational
175
Parkville, South Brisbane
2025-12-17
Recruiting
Study of DONQ52 in Active Celiac Disease
NCT07239336Celiac Disease
Chugai Pharmaceutical
Phase 2
92
Campbelltown, North Sydney, Morayfield, Sippy Downs, South Brisbane, Box Hill, Parkville, Midland
2025-12-16
Active, closed
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
NCT07220811Immune System Diseases, Ig-E Mediated Food Allergy
DrugOzureprubart
RAPT Therapeutics, Inc., a member of the GSK plc group of companies
Phase 2
110
Darlinghurst, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Parkville Melbourne, Murdoch
2025-12-15
Recruiting
Angitia Incorporated Limited
Phase 2
80
Melbourne, Parkville, Saint Leonards, Westmead
2025-12-12
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
NCT07144163Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 3
150
Herston, Woolloongabba, Adelaide, Parkville, Nedlands
2025-12-11
Active, closed
Boehringer Ingelheim
Phase 3
135
Westmead, South Brisbane, Clayton, Parkville
2025-12-09
Recruiting
Duke University
Phase 2
92
Parkville
2025-11-28
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Kingswood, Kogarah, Randwick, Douglas, South Brisbane, Melbourne, Parkville, Nedlands
2025-11-25
Recruiting
SAb Biotherapeutics, Inc.
Phase 2
159
Brisbane, Nedlands, Parkville, St Leonards, Westmead
2025-11-25
Recruiting
Hoffmann-La Roche
Phase 3
900
Kogarah, Westmead, Woolloongabba, Clayton, Parkville, Prahan, Nedlands
2025-11-24
Active, closed
Hoffmann-La Roche
Phase 1
3
Westmead, Clayton, Parkville
2025-11-19
Recruiting
QED Therapeutics, a BridgeBio company
Phase 2
77
Parkville
2025-11-19
Active, closed
SOS for Caregiver Wellbeing
NCT07136584Mental Health, Depression and Burden in Caregivers, Anxiety Depression, Stress
Murdoch Childrens Research Institute
Not applicable
123
Parkville
2025-10-22
Recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
120
Adelaide, Parkville, South Brisbane
2025-10-20
Recruiting
Murdoch Childrens Research Institute
Observational
150
Parkville
2025-10-15
Active, closed
Janssen Research & Development, LLC
Phase 3
896
Clayton, Concord, Fitzroy, Murdoch, New Lambton, Parkville, South Brisbane
2025-10-01
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
30
Gosford, Parkville, Southport
2025-09-19
Recruiting
Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NCT07055542Allergic Asthma, Thunderstorm Asthma, Seasonal Allergic Rhinitis, Grass Pollen Allergy
University of Melbourne
Not applicable
530
Albury, Box Hill, Clayton, Heidelberg, Melbourne, Parkville
2025-08-27
Recruiting
Basilea Pharmaceutica
Phase 3
234
Nedlands, Clayton, Melbourne, Parkville, Westmead, Woolloongabba
2025-08-26
Recruiting
University of Minnesota
Observational
1,500
Camperdown, Sydney, Westmead, Brisbane, Clayton, Heidelberg, Melbourne, Parkville
2025-08-25
Recruiting
Study of BHV-1300 in Graves' Disease
NCT06980649Graves Disease
DrugBHV-1300
Biohaven Therapeutics Ltd.
Phase 1
15
Fitzroy, Herston, Kotara, Melbourne, Oaklands Park, Parkville, St Leonards, Torquay
2025-08-21
Recruiting
Neurocrine Biosciences
Phase 3
550
Carlton, Melbourne, Parkville
2025-08-18
Recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
240
South Brisbane, Adelaide, Parkville
2025-08-11
Active, closed
Novo Nordisk A/S
Phase 3
877
Macquarie Park, Wollongong, Townsville, Oaklands Park, Fitzroy, Heidelberg Heights, Parkville
2025-08-11
Recruiting
BioMarin Pharmaceutical
Phase 2
60
South Brisbane, Parkville
2025-07-30
Recruiting
Azafaros B.V.
Phase 3
72
North Adelaide, Parkville
2025-06-30
Recruiting
Azafaros B.V.
Phase 3
147
North Adelaide, Parkville
2025-06-30
Active, closed
DBV Technologies
Phase 3
480
Westmead, South Brisbane, Parkville, Richmond, Nedlands
2025-06-24
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Melbourne, Parkville, Liverpool, St Leonards
2025-06-23
By invitation
BioMarin Pharmaceutical
Phase 3
140
Parkville
2025-06-20
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Sydney, Warrawong, Brisbane, Douglas, Southport, Box Hill, Geelong, Parkville
2025-06-19
Recruiting
BlueRock Therapeutics
Phase 3
102
Randwick, Southport, Woolloongabba, Clayton, Melbourne, Parkville
2025-06-17
Recruiting
Relay Therapeutics, Inc.
Phase 2
277
Randwick, South Brisbane, Clayton, Parkville
2025-06-13
Active, closed
Biogen
Phase 3
255
Randwick, Parkville
2025-06-09
Recruiting
Celgene
Phase 2
200
Newcastle, Sydney, Kent Town, Hobart, Box Hill, Heidelberg, Parkville, Nedlands
2025-06-05
Active, closed
Apogee Therapeutics, Inc.
Phase 1
86
Darlinghurst, Kogarah, Westmead, Woolloongabba, Carlton, East Melbourne, Mitcham, Parkville
2025-06-04
Active, closed
Boston Scientific Corporation
Not applicable
376
New Lambton Heights, Westmead, Brisbane, Clayton, Parkville, Melbourne
2025-06-03
Recruiting
Odyssey Therapeutics, Inc.
Phase 2
57
Birtinya, Box Hill, Maroochydore, Melbourne, Murdoch, Parkville
2025-06-02
Recruiting
National Cancer Institute (NCI)
Phase 2
222
Hunter Regional Mail Centre, South Brisbane, Parkville, Perth
2025-05-30
Active, closed
Skyhawk Therapeutics, Inc.
Phase 2/3
120
New Lambton Heights, Westmead, Herston, Adelaide, Launceston, Caulfield South, Parkville, Nedlands
2025-05-27
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
50
Sydney, Brisbane, Parkville
2025-05-26
Recruiting
Hoffmann-La Roche
Phase 3
425
Macquarie Park, Wahroonga, Mackay, Adelaide, Footscray, Parkville
2025-05-12
Recruiting
Takeda
Phase 3
225
Garran, Sydney, Douglas, Adelaide, Box Hill, Fitzroy, Melbourne, Parkville
2025-05-06
Recruiting
Hoffmann-La Roche
Phase 1
405
Darlinghurst, Parkville
2025-04-30
By invitation
QED Therapeutics, a BridgeBio company
Phase 2/3
24
Parkville
2025-04-22
Recruiting
Priovant Therapeutics, Inc.
Phase 2/3
168
Melbourne, Parkville
2025-04-09
Recruiting
Vifor Pharma, Inc.
Phase 2
36
Clayton, Parkville, Westmead
2025-04-06
Active, closed
Orygen
Phase 2
75
Parkville
2025-04-01
Recruiting
EMVision Medical Devices Ltd
Observational
300
Liverpool, Parkville
2025-03-26
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Macquarie Park, Parkville, Woolloongabba
2025-03-18
Recruiting
Tyra Biosciences, Inc
Phase 2
92
Westmead, Parkville
2025-03-04
Active, closed
Sanofi
Phase 2
84
Saint Leonards, Brisbane, Parkville
2025-02-28
Recruiting
Comanche Biopharma
Phase 1
60
Parkville, Melbourne
2025-02-26
Recruiting
Gain Therapeutics, Inc.
Phase 1
20
Darlinghurst, Kogarah, Westmead, Woolloongabba, Adelaide, Melbourne, Parkville
2025-02-21
By invitation
Longboard Pharmaceuticals
Phase 3
324
Randwick, Westmead, Brisbane, Heidelberg, Parkville
2025-02-12
By invitation
Pharvaris Netherlands B.V.
Phase 3
170
Box Hill, Parkville, Perth, Sydney
2025-02-01
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Phillip, Sydney, Westmead, Melbourne, Parkville
2025-01-31
Recruiting
University of Melbourne
Not applicable
25
Parkville
2025-01-24
Recruiting
Cullinan Therapeutics Inc.
Phase 1
24
Parkville, Victoria Park
2025-01-21
Active, closed
Intellia Therapeutics
Phase 3
80
Campbelltown, Melbourne, Parkville
2025-01-15
Active, closed
Pfizer
Phase 3
1,035
Douglas, Woolloongabba, Capel Sound, Frankston, Melbourne, Parkville
2025-01-06
Recruiting
Supernus Pharmaceuticals, Inc.
Phase 2
216
Herston, Adelaide, Clayton, Fitzroy, Melbourne, Parkville, Nedlands
2024-12-30
Recruiting
Sanofi
Phase 2
84
Garran, Parkville
2024-12-19
Active, closed
argenx
Phase 3
154
Parkville, Southport, Sydney, Woolloongabba
2024-12-18
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 3
1,714
Westmead, Brisbane, Southport, Parkville, Perth
2024-12-18
Not yet open
Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure
NCT06681636HPV Infection, Cervical Cancer, Anogenital Cancer, Anogenital Warts
DrugHPV nonavalent vaccine
National Institute of Hygiene and Epidemiology, Vietnam
Phase 2
300
Parkville
2024-12-14
Active, closed
Hoffmann-La Roche
Phase 3
350
Macquarie Park, Parkville
2024-12-11
Recruiting
Basilea Pharmaceutica
Phase 3
450
Sydney, Woolloongabba, Melbourne, Parkville, Clayton
2024-12-11
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 2
130
Camperdown, Herston, Nedlands, North Ryde, Parkville
2024-12-06
Recruiting
Using Artificial Intelligence to Screen for Hip Dysplasia
NCT06647225Developmental Dysplasia of Hip
Murdoch Childrens Research Institute
Not applicable
240
Parkville
2024-12-06
Active, closed
BioMarin Pharmaceutical
Phase 2
30
Saint Leonards, South Brisbane, Parkville
2024-11-22
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
50
Nedlands, Parkville, South Brisbane
2024-11-21
Recruiting
Genentech, Inc.
Phase 1
410
Darlinghurst, Mount Kuring-Gai, Parkville
2024-11-14
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Concord, Kingswood, Liverpool, Westmead, Clayton, Heidelberg, Parkville, Perth
2024-11-12
Active, closed
Longboard Pharmaceuticals
Phase 3
367
Randwick, Westmead, Brisbane, Heidelberg, Melbourne, Parkville
2024-11-11
Active, closed
Alnylam Pharmaceuticals
Phase 1/2
89
Camperdown, Parkville
2024-11-07
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
NCT06368817Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma, Pineal Region Germinoma
DrugsParaplatin·Etoposide·Carboplatin
Children's Oncology Group
Phase 2
240
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2024-10-22
Recruiting
BioMarin Pharmaceutical
Phase 2
100
Parkville
2024-10-21
Active, closed
Uniquity One (UNI)
Phase 2
184
Newcastle, Maroochydore, South Brisbane, Woolloongabba, Box Hill, Fitzroy, Parkville, Murdoch
2024-10-16
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Concord, Kingswood, Liverpool, Westmead, Birtinya, Clayton, Heidelberg, Parkville
2024-10-14
Active, closed
Longboard Pharmaceuticals
Phase 3
108
Randwick, Westmead, Brisbane, Heidelberg, Melbourne, Parkville
2024-09-25
Recruiting
A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
NCT05983159Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations, Venous Malformation
DrugsMirdametinib·Alpelisib
Murdoch Childrens Research Institute
Phase 2
50
Parkville
2024-09-13
Active, closed
Takeda
Phase 3
2,099
Kogarah, Benowa, Carlton, Parkville
2024-09-04
Not yet open
University of Melbourne
Not applicable
30
Newcastle, St Leonards, Adelaide, Melbourne, Parkville
2024-08-01
Recruiting
Basking Biosciences, Inc.
Phase 2
228
New Lambton Heights, Woolloongabba, Adelaide, Clayton, Parkville, Murdoch
2024-07-31
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-07-30
Active, closed
Biosense Webster, Inc.
Not applicable
354
Adelaide, Parkville
2024-06-28
Active, closed
BioMarin Pharmaceutical
Phase 3
80
Parkville
2024-06-17
Recruiting
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
NCT06557265Lupus Nephritis, Primary Membranous Nephropathy
DrugNKX019
Nkarta, Inc.
Phase 1/2
120
Parkville
2024-06-13
Recruiting
QED Therapeutics, a BridgeBio company
Observational
150
Parkville
2024-06-05
Recruiting
The George Institute
Phase 4
162
Camperdown, Randwick, St Leonards, Warners Bay, Southport, Melbourne, Parkville
2024-06-03
Recruiting
Western Sydney Local Health District
Phase 2
160
Westmead, Herston, Parkdale, Parkville, Nedlands
2024-06-01
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Concord, Westmead, Clayton, Parkville
2024-05-20
Active, closed
Alnylam Pharmaceuticals
Phase 2
210
Adelaide, Brisbane, Heidelberg, Nedlands, Parkville
2024-05-17
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
30
Nedlands, Parkville
2024-05-14
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-05-13
By invitation
Travere Therapeutics, Inc.
Phase 3
100
Adelaide, Parkville, Westmead
2024-04-30
Recruiting
National Cancer Institute (NCI)
Phase 3
478
Randwick, Westmead, South Brisbane, Parkville, Perth
2024-04-19
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
NCT05828069Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
DrugTovorafenib
National Cancer Institute (NCI)
Phase 2
48
Hunter Regional Mail Centre, Randwick, South Brisbane, Parkville, Perth
2024-03-28
Active, closed
Bristol-Myers Squibb
Phase 2
310
East Gosford, Macquarie Park, Griffith University, Carlton North, Ivanhoe, Malvern, Melbourne, Parkville
2024-03-20
Active, closed
Tavotek Biotherapeutics
Phase 2
20
Parkville
2024-03-15
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Benowa, Clayton, Kogarah, Melbourne, Mitcham, Parkville
2024-03-09
Recruiting
PTC Therapeutics
Phase 3
56
Nedlands, North Adelaide, Parkville, South Brisbane
2024-03-04
Active, closed
Murdoch Childrens Research Institute
Phase 1/2
10
Parkville
2024-02-19
Active, closed
AbbVie
Observational
427
Westmead, Parkville
2024-01-24
Recruiting
Ascendis Pharma A/S
Phase 2
72
Parkville
2024-01-23
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 1/2
85
Parkville
2024-01-04
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
124
Clayton, Herston, Parkville, St Leonards
2024-01-03
Recruiting
Travere Therapeutics, Inc.
Phase 3
70
Adelaide, Parkville, Westmead
2023-12-28
Active, closed
argenx
Observational
413
Parkville, Southport, Woolloongabba
2023-11-29
Recruiting
BioMarin Pharmaceutical
Observational
400
Parkville
2023-11-27
Recruiting
Takeda
Phase 3
80
Randwick, Woollangabba, Parkville, Nedlands
2023-11-13
Active, closed
VOLT CE Mark Study
NCT06106594Atrial Arrhythmia, Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
Abbott Medical Devices
Not applicable
300
Chermside, Adelaide, Clayton, Parkville
2023-10-24
Active, closed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2
78
Saint Leonards, South Brisbane, Adelaide, Melbourne, Parkville, Nedlands
2023-10-19
Recruiting
Australasian Leukaemia and Lymphoma Group
Phase 2
42
Parkville, Nedlands
2023-10-12
Active, closed
Janssen Research & Development, LLC
Phase 3
684
East Melbourne, Greenslopes, Melbourne, Miranda, Mitcham, Parkville
2023-10-12
Recruiting
AbbVie
Phase 3
1,500
Darlinghurst, Kogarah, Coorparoo, Woolloongabba, Carlton, East Melbourne, Parkville, Fremantle
2023-10-11
Recruiting
AbbVie
Phase 3
90
Clayton, Parkville
2023-10-02
Recruiting
The Florey Institute of Neuroscience and Mental Health
Phase 2
80
Camperdown, Liverpool, New Lambton Heights, Randwick, Adelaide, Box Hill, Parkville
2023-09-27
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 2
40
Woolloongabba, Bedford Park, Parkville
2023-09-07
By invitation
Disc Medicine, Inc
Phase 2/3
230
Camperdown, Parkville
2023-08-31
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,769
Box Hill, Clayton, Melbourne, Midland, Nedlands, North Adelaide, Parkville, South Brisbane
2023-08-30
By invitation
Vertex Pharmaceuticals Incorporated
Phase 3
174
Nedlands, North Adelaide, Parkville, South Brisbane
2023-08-11
Active, closed
Hoffmann-La Roche
Phase 3
459
Kingswood, Kogarah, Liverpool, Woolloongabba, Adelaide, Parkville, St Albans
2023-08-08
Recruiting
ADARx Pharmaceuticals, Inc.
Phase 1/2
50
Brisbane, Melbourne, Parkville
2023-08-07
Recruiting
Orygen
Phase 2
100
Parkville
2023-07-27
Recruiting
Friedreich's Ataxia Research Alliance
Observational
3,000
Parkville
2023-06-28
Active, closed
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy
Theravance Biopharma
Phase 3
102
Clayton, Melbourne, Parkville
2023-06-27
Active, closed
Population Health Research Institute
Not applicable
5,100
Westmead, Bedford Park, Box Hill, Campbelltown, Chermside, Gosford, Melbourne, Parkville
2023-06-22
By invitation
Ascendis Pharma Growth Disorders A/S
Phase 2/3
140
Parkville
2023-06-21
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
23
Brisbane, Clayton, Parkville, Perth
2023-06-16
Recruiting
ModernaTX, Inc.
Observational
60
Parkville
2023-06-16
Active, closed
MapLight Therapeutics
Phase 2
120
Camperdown, Parkville
2023-06-01
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
148
Westmead, Parkville
2023-05-31
Recruiting
Takeda
Phase 3
240
Westmead, South Brisbane, Clayton, Parkville
2023-05-16
Recruiting
The Bionics Institute of Australia
Not applicable
40
East Melbourne, Fitzroy, Geelong, Moonee Ponds, Parkville
2023-05-02
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Randwick, Camperdown, Fitzroy, Heidelberg, Kogarah, Melbourne, Parkville, South Brisbane
2023-04-25
Recruiting
Eupraxia Pharmaceuticals Inc.
Phase 1/2
117
Sydney, Brisbane, Maroochydore, Adelaide, Box Hill, Epping, Melbourne, Parkville
2023-03-31
Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
NCT05735080Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
DrugsAbemaciclib·Fulvestrant
Incyclix Bio
Phase 1/2
150
Frankston, Parkville, South Brisbane
2023-03-28
Active, closed
Murdoch Childrens Research Institute
Not applicable
441
Randwick, North Adelaide, Parkville, Nedlands
2023-03-22
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugsTovorafenib·Carboplatin
Day One Biopharmaceuticals, Inc.
Phase 3
418
South Brisbane, Nedlands, North Adelaide, Parkville, Randwick, Westmead
2023-02-27
Active, closed
DBV Technologies
Phase 3
600
Adelaide, Nedlands, Parkville, Richmond, South Brisbane, Westmead
2023-02-21
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Kogarah, South Brisbane, Melbourne, Heidelberg, Parkville
2023-02-14
Active, closed
A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy
NCT05621317Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis, Immune System Diseases
Aravax Pty Ltd
Phase 2
95
Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Nedlands
2023-02-09
Recruiting
Supernus Pharmaceuticals, Inc.
Phase 2
60
Randwick, Sydney, Brisbane, Box Hill, Heidelberg, Melbourne, Parkville
2023-02-07
Active, closed
Hoffmann-La Roche
Phase 2
301
Clayton, Parkville, Nedlands
2023-02-03
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Concord, Fitzroy, Melbourne, Parkville
2023-01-16
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Clayton, Adelaide, New Lambton Heights, Parkville, Perth, South Brisbane, Sydney, Westmead
2022-12-15
Recruiting
Pharming Technologies B.V.
Phase 2
180
Randwick, Saint Leonards, Parkville, Nedlands
2022-12-13
Recruiting
Pfizer
Phase 3
100
Parkville
2022-12-09
Active, closed
Novartis Pharmaceuticals
Phase 3
696
East Melbourne, Parkville
2022-12-09
Active, closed
PTC Therapeutics
Phase 3
130
Parkville
2022-12-08
Active, closed
Pfizer
Phase 1
148
Melbourne, Parkville
2022-11-30
Active, closed
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
NCT05286801Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma, Malignant Solid Neoplasm
DrugsTiragolumab·Tecentriq·Atezolizumab
National Cancer Institute (NCI)
Phase 1/2
86
Randwick, South Brisbane, Parkville
2022-11-17
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Camperdown, Chermside, Melbourne, Nedlands, Parkville, South Brisbane, Westmead
2022-11-08
Recruiting
Bayer
Phase 3
100
South Brisbane, Clayton, Parkville
2022-11-08
Recruiting
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
NCT05504291Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Group D Retinoblastoma, Stage I Retinoblastoma
DrugsVincrystine·Melphalan·Paraplatin·Vincristine
Children's Oncology Group
Phase 2
26
Parkville, Perth
2022-11-04
Active, closed
Amicus Therapeutics
Phase 3
14
Parkville, Perth
2022-10-31
Recruiting
Stalicla SA
Observational
1,500
South Brisbane, Bedford Park, Melbourne, Parkville
2022-10-13
Active, closed
Genmab
Phase 1
17
Westmead, Parkville, Perth
2022-10-04
Active, closed
PedAL BCU, LLC
Phase 3
120
South Brisbane, Parkville, Nedlands
2022-10-01
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Adelaide, Fitzroy, Liverpool, Murdoch, Newtown, North Terrace, Parkville, Perth
2022-09-27
Active, closed
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
NCT05483868Non-muscle-invasive Bladder Cancer, NMIBC, Non-Muscle Invasive Bladder Carcinoma, Non-Muscle Invasive Bladder Neoplasms
DrugBel-sar
Aura Biosciences
Phase 1
55
Westmead, Heidelberg, Langwarrin, Parkville, Nedlands
2022-09-26
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Adelaide, Camperdown, Clayton, Herston, Murdoch, Parkville, South Brisbane, Woodville South
2022-09-13
Recruiting
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
NCT05465174Craniopharyngioma, Child, Craniopharyngioma, Recurrent Craniopharyngioma
DrugTovorafenib
Sabine Mueller, MD, PhD
Phase 2
57
New Lambton Heights, Hobart, Clayton, Parkville, Nedlands
2022-09-12
Active, closed
Sanofi
Phase 2/3
1,856
Westmead, Greenslopes, Carlton, Melbourne, Parkville, Traralgon
2022-08-22
Active, closed
AbbVie
Observational
785
Blacktown, Kingswood, North Mackay, Heidelberg, Parkville
2022-08-15
Active, closed
Dyne Therapeutics
Phase 1/2
86
Westmead, Parkville
2022-08-12
Recruiting
International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery
NCT05673499Congenital Disorders, Cerebral Desaturation, Neonatal Surgery
Children's Hospital of Philadelphia
Observational
900
Nedlands, Parkville
2022-08-12
Recruiting
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
NCT05376267Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced, Hypoxia-Ischemia, Brain
University of Michigan
Not applicable
900
Brisbane, Douglas, Southport, North Adelaide, Clayton, Parkville, Nedlands
2022-08-05
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Adelaide, Box Hill, Clayton, Footscray, Melbourne, Newtown, North Terrace, Parkville
2022-07-22
Recruiting
Otoferlin Gene-mediated Hearing Loss Natural History Study
NCT05572073Sensorineural Hearing Loss, Bilateral
Akouos, Inc.
Observational
150
Parkville
2022-07-14
Active, closed
Pfizer
Phase 2
108
Heidelberg, Melbourne, Parkville
2022-07-11
Active, closed
Albireo, an Ipsen Company
Phase 3
180
Parkville
2022-07-05
Recruiting
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
NCT05230758Medulloblastoma, Childhood, Cognitive Impairment
DrugGlucophage
Donald Mabbott
Phase 3
140
New Lambton Heights, Westmead, Adelaide, Clayton, Parkville, Nedlands
2022-07-01
Recruiting
IntraBio Inc
Phase 3
53
Parkville
2022-06-30
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
210
Nedlands, North Adelaide, Parkville, South Brisbane
2022-06-21
Recruiting
Edwards Lifesciences
Not applicable
1,234
Spring Hill, Adelaide, Parkville
2022-06-20
Active, closed
AMP SCZ® Observational Study: PREDICT-DPACC
NCT05905003Clinical High Risk, Psychosis, Remission, Conversion
Brigham and Women's Hospital
Observational
2,617
Adelaide, Craigieburn, Glenroy, Melton South, Parkville, Sunshine, Werribee
2022-06-02
Active, closed
National Cancer Institute (NCI)
Phase 1/2
132
Randwick, Westmead, South Brisbane, Parkville, Perth
2022-05-31
Recruiting
Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children
NCT04876131Complicated Urinary Tract Infection, Infection, Pediatric Infectious Disease
Murdoch Childrens Research Institute
Phase 4
396
Adelaide, Geelong, Melbourne, Parkville, Perth
2022-05-30
Active, closed
Hoffmann-La Roche
Phase 3
188
Parkville
2022-05-19
Recruiting
Incyte Corporation
Phase 2
98
St Leonards, Parkville
2022-05-05
Recruiting
PedAL BCU, LLC
Phase 1/2
960
Westmead, South Brisbane, Parkville, Perth
2022-04-18
Active, closed
Bausch Health Americas, Inc.
Phase 3
524
Concord, Kingswood, Bedford Park, Box Hill, Parkville, Murdoch, Perth
2022-04-07
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
NCT05235165Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma, Osteosarcoma
Children's Oncology Group
Phase 3
62
Westmead, Parkville, Perth
2022-04-01
Active, closed
Bayer
Phase 3
219
South Brisbane, Clayton, Parkville
2022-03-28
Active, closed
Sanofi
Phase 3
122
Parkville
2022-03-11
Recruiting
Takeda
Phase 3
120
Westmead, South Brisbane, Clayton, Parkville
2022-02-10
Active, closed
Amgen
Phase 1/2
329
Camperdown, East Melbourne, Parkville
2022-02-01
By invitation
QED Therapeutics, a BridgeBio company
Phase 2
325
Parkville
2021-12-06
Active, closed
Novartis Pharmaceuticals
Phase 3
129
Parkville
2021-10-05
Active, closed
National Cancer Institute (NCI)
Phase 3
244
Hunter Regional Mail Centre, Westmead, South Brisbane, Parkville, Perth
2021-10-05
Recruiting
Murdoch Childrens Research Institute
Observational
150,000
Parkville
2021-10-04
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Woolloongabba, Adelaide, Parkville
2021-09-20
Active, closed
Hoffmann-La Roche
Phase 1/2
42
Randwick, Parkville
2021-09-14
Active, closed
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
NCT04994132Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Metastatic Embryonal Rhabdomyosarcoma
DrugsDactinomycin·Vinorelbine·Cytoxan·Vincristine
Children's Oncology Group
Phase 3
113
Hunter Regional Mail Centre, Randwick, Westmead, Parkville, Perth
2021-09-14
Active, closed
Long-Term Follow-up of Subjects Who Were Treated With ST-920
NCT05039866Fabry Disease, Fabry Disease, Cardiac Variant
Sangamo Therapeutics
Observational
32
Parkville
2021-08-16
Active, closed
Pfizer
Phase 3
118
Parkville
2021-08-12
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Randwick, Parkville
2021-08-12
Active, closed
Tanabe Pharma America, Inc.
Phase 3
286
Brisbane, Parkville
2021-08-10
Recruiting
The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
NCT04284839Bleeding Post Cardiac Surgery, Indication for Anticoagulation
DrugsDOAC·Dabigatran·Edoxaban·Warfarin
Population Health Research Institute
Phase 3
3,500
Fitzroy, Parkville
2021-07-18
Recruiting
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
NCT04684368Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma, Immature Teratoma
DrugsUromitexan·Tripegfilgrastim·Mesna·Isophosphamide
Children's Oncology Group
Phase 2
160
Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2021-07-13
Active, closed
PreludeDx
Observational
1,500
Alexandria, Parkville
2021-07-02
Active, closed
Murdoch Childrens Research Institute
Not applicable
293
Parkville
2021-06-24
Active, closed
McGill University Health Centre/Research Institute of the McGill University Health Centre
Not applicable
617
Garran, Adelaide, Melbourne, Parkville
2021-06-01
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
54
Parkville
2021-06-01
Active, closed
Murdoch Childrens Research Institute
Not applicable
906
South Brisbane, Adelaide, Melbourne, Parkville, Subiaco
2021-05-04
Recruiting
Day One Biopharmaceuticals, Inc.
Phase 2
141
Brisbane, Parkville, Perth, Randwick, Westmead
2021-04-22
Recruiting
Syndax Pharmaceuticals
Phase 2
296
Parkville, Westmead
2021-03-04
Active, closed
Hoffmann-La Roche
Phase 3
55
Westmead, Parkville, Nedlands
2021-02-04
Active, closed
Hoffmann-La Roche
Phase 2
920
Darlinghurst, Woolloongabba, Melbourne, Parkville
2021-01-18
Active, closed
Children's Oncology Group
Phase 2
41
Westmead, South Brisbane, Parkville, Perth
2020-12-31
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
DrugsPrifetrastat·Atirmociclib·Palbociclib·Letrozole
Pfizer
Phase 2
320
Camperdown, Adelaide, Melbourne, Parkville, St Albans, Subiaco
2020-11-16
Recruiting
University of Melbourne
Not applicable
240
Newcastle, Sydney, Brisbane, Southport, Adelaide, Melbourne, Parkville
2020-11-15
Active, closed
Pfizer
Phase 3
114
Westmead, Parkville, Nedlands
2020-11-05
Active, closed
Hoffmann-La Roche
Phase 3
985
Camperdown, Liverpool, New Lambton, Woolloongabba, Box Hill, Heidelberg, Parkville
2020-10-26
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
NCT04322318Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor, Stage II Kidney Wilms Tumor, Stage III Kidney Wilms Tumor
DrugsIsophosphamide·Vincrystine·Ifosfamide·Topotecan
Children's Oncology Group
Phase 2
256
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Perth
2020-10-19
Active, closed
BioMarin Pharmaceutical
Phase 2
20
Parkville
2020-10-10
Active, closed
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
NCT04323046Glioblastoma, Malignant Glioma, Recurrent Glioblastoma, Recurrent Malignant Glioma
DrugsOpdivo·Nivolumab
Sabine Mueller, MD, PhD
Phase 1
9
Sydney, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2020-10-02
Active, closed
Eli Lilly and Company
Phase 3
996
Concord, Sydney, Brisbane, Maroochydore, Adelaide, Parkville, Murdoch
2020-06-22
Active, closed
Eli Lilly and Company
Phase 3
1,736
Erina, Sydney, Carlton, Glen Iris, Malvern, Melbourne, Parkville
2020-06-19
Recruiting
University Hospital Heidelberg
Phase 1/2
91
Randwick, Westmead, Parkville, Nedlands
2020-05-26
Recruiting
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
NCT04310930Pulmonary Disease Due to Mycobacteria (Diagnosis)
DrugsImipenem·Co-trimoxazole·Rifabutin·Tigecycline
The University of Queensland
Phase 2/3
300
Kogarah, South Brisbane, Woolloongabba, Heidelberg, Parkville, Perth, Adelaide, Birtinya
2020-03-02
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
NCT04071847Movement Disorders, Parkinson Disease, Essential Tremor, Tremor
Abbott Medical Devices
Observational
1,000
Woolloongabba, Parkville
2019-11-26
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Melbourne, Parkville, Murdoch
2019-11-13
Active, closed
Children's Oncology Group
Phase 2
110
Hunter Regional Mail Centre, Westmead, Clayton, Parkville, Perth
2019-11-08
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
NCT04065399Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Lineage Acute Leukemia, Mixed Phenotype Acute Leukemia
DrugsCobicistat·Revumenib
Syndax Pharmaceuticals
Phase 1/2
447
Melbourne, Parkville, Nedlands, Saint Leonards
2019-11-05
Active, closed
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
163
Darlinghurst, Parkville
2019-11-04
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
NCT03959085B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Central Nervous System Leukemia, Mixed Phenotype Acute Leukemia
DrugsCalaspargase Pegol·Tioguanin·Thioguanine·Oncaspar
Children's Oncology Group
Phase 3
5,951
Hunter Regional Mail Centre, Westmead, South Brisbane, North Adelaide, Saint Hobart, Clayton, Parkville, Perth
2019-10-31
Active, closed
Novo Nordisk A/S
Phase 3
134
Melbourne, Parkville, Murdoch
2019-10-21
Active, closed
Biogen
Phase 3
152
Parkville
2019-10-18
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
North Sydney, Westmead, Heidelberg, Melbourne, Parkville, Nedlands
2019-10-02
Active, closed
Sanofi
Observational
1,860
Kogarah, Sydney, Melbourne, Parkville, Richmond
2019-08-15
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Camperdown, Heidelberg, Parkville
2019-08-12
Recruiting
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
NCT03717623Posaconazole, Pharmacokinetics, Invasive Candidiases, Invasive Aspergillosis
Melbourne Health
Phase 4
100
Parkville
2019-08-01
Active, closed
Children's Oncology Group
Phase 2
94
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2019-07-08
Active, closed
National Cancer Institute (NCI)
Phase 3
6,720
Hunter Regional Mail Centre, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Perth
2019-07-03
Active, closed
BioMarin Pharmaceutical
Phase 2
73
Westmead, Parkville
2019-06-12
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Box Hill, Darlinghurst, Heidelberg, Malvern, Parkville, St Leonards, Wahroonga, Westmead
2019-06-11
Recruiting
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
NCT05651347Fetal Growth Retardation, Stillbirth and Fetal Death, Pregnancy Preterm
DrugMelatonin
Monash University
Phase 3
336
Camperdown, Newcastle, South Brisbane, Southport, North Adelaide, Clayton, Heidelberg, Parkville
2019-05-29
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Randwick, Westmead, Parkville, South Brisbane
2019-05-09
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
NCT05685745Infant, Extremely Premature, Obstetric Labor, Premature, Premature Birth, Intensive Care, Neonatal
The University of Texas Health Science Center, Houston
Observational
5,000
South Brisbane, Heidelberg, Parkville, Perth
2019-01-01
Active, closed
Children's Oncology Group
Phase 2
38
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Clayton, Parkville, Perth
2018-11-06
Active, closed
Eli Lilly and Company
Phase 3
1,058
Adelaide, Box Hill, Brisbane, Maroochydore, Melbourne, Parkville
2018-07-18
Active, closed
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
NCT03533582Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma, Hepatoblastoma
DrugsSorafenib·Cis-platinum·CDDP·Platinol-AQ
Children's Oncology Group
Phase 3
537
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2018-05-24
Active, closed
AstraZeneca
Phase 3
1,018
Auchenflower, Box Hill, Brisbane, Kogarah, Orange, Parkville, Westmead, Wollongong
2018-05-14
By invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
NCT06041906Congenital Portosystemic Shunt, CPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin
Observational
500
Parkville
2018-04-26
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Adelaide, Clayton, Concord, Heidelberg, Nedlands, North Terrace, Parkville, Penrith
2018-04-13
Active, closed
University of Melbourne
Phase 3
760
Heidelberg, Parkville
2018-03-06
Active, closed
EBR Systems, Inc.
Not applicable
300
Garran, New Lambton Heights, Randwick, Wahroonga, Chermside, Adelaide, Clayton, Parkville
2018-01-17
Active, closed
Gilead Sciences
Phase 3
340
Herston, Melbourne, Parkville
2017-12-12
Active, closed
BioMarin Pharmaceutical
Phase 3
119
Westmead, Parkville
2017-12-12
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Randwick, Westmead, Brisbane, Adelaide, Bedford Park, Parkville, Perth
2017-08-10
Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
NCT03067181Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor, Malignant Germ Cell Tumor
DrugsBleomycin·Cis-platinum·CDDP·Platinol-AQ
Children's Oncology Group
Phase 3
1,780
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Clayton, Parkville, Perth
2017-05-25
Active, closed
St. Jude Children's Research Hospital
Phase 2/3
790
Parkville
2017-03-29
Active, closed
AbbVie
Phase 3
443
Woolloongabba, Adelaide, Melbourne, Parkville, Nedlands, Perth
2017-02-02
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Albury, Tweed Heads, Wahroonga, Ashford, Ballarat, East Bentleigh, Malvern, Parkville
2016-12-22
Active, closed
BioMarin Pharmaceutical
Phase 2
30
Parkville
2016-01-26
Active, closed
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
NCT02521493Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome, Myeloid Leukemia Associated With Down Syndrome
DrugsL-Asp·Leucogen·L-Asparaginase·Asparaginase
Children's Oncology Group
Phase 3
280
Hunter Regional Mail Centre, Randwick, Westmead, Parkville, Perth
2015-12-23
Active, closed
Bayer
Phase 1/2
154
Sydney, North Adelaide, Parkville
2015-12-16
Recruiting
Project: Every Child for Younger Patients With Cancer
NCT02402244Adrenal Gland Pheochromocytoma, Carcinoma In Situ, Central Nervous System Neoplasm, Childhood Immature Teratoma
Children's Oncology Group
Observational
75,000
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Saint Hobart, Clayton, Parkville
2015-11-03
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Camperdown, Melbourne, Parkville, Murdoch, Herston
2015-11-02
Active, closed
Children's Oncology Group
Phase 3
158
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2015-07-21
Active, closed
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
NCT02381886Advanced Malignancies That Harbor IDHR132 Mutations
Novartis Pharmaceuticals
Phase 1
166
Melbourne, Parkville
2015-03-06
Active, closed
Exelixis
Phase 4
247
St Leonards, Herston, Kurralta Park, Parkville
2015-02-25
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Clayton, Parkville, Herston, South Brisbane
2015-01-20
Active, closed
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
NCT02112916Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood Lymphoblastic Lymphoma, Ann Arbor Stage III Adult Lymphoblastic Lymphoma
DrugsHydrocortisone Sodium Succinate·Isophosphamide·Tioguanin·Thioguanine
National Cancer Institute (NCI)
Phase 3
847
Hunter Regional Mail Centre, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Perth
2014-10-04
Active, closed
Novartis Pharmaceuticals
Phase 1/2
259
Westmead, Parkville, Nedlands
2013-10-22
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Heidelberg, Parkville, Randwick
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Heidelberg, Parkville, Randwick
2013-08-26
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Parkville
2013-07-26
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Westmead, Cairns, Herston, Woolloongabba, Adelaide, Heidelberg, Parkville, Murdoch
2013-03-18
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Westmead, Melbourne, Perth, Parkville
2012-07
Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
NCT02493478Failed or Difficult Intubation, Sequela, Intubation; Difficult, Intubation Complication
Children's Hospital of Philadelphia
Observational
150,000
Herston, Parkville
2010-03
Active, closed
AstraZeneca
Phase 2
162
Parkville, Randwick
2010-02-04
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
St Leonards, Sydney, Brisbane, Parkville, Bedford Park, Heidelberg, Hobart, Melbourne
2007-12
Recruiting
TrialNet Pathway to Prevention of T1D
NCT00097292Diabetes Mellitus, Type 1
University of South Florida
Observational
75,000
Parkville
2004-02-01
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Westmead, Brisbane, Adelaide, Parkville, Perth
2001-07-31
Active, closed
FA Clinical Outcome Measures
NCT03090789Friedreich Ataxia, Neuro-Degenerative Disease
Friedreich's Ataxia Research Alliance
Observational
2,000
Parkville
2001-01-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Sydney, Westmead, Brisbane, Townsville, Adelaide, Hobart, Clayton, Parkville
1991-04-01
Rows per page Showing 1–320 of 320
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-australia/city/parkville

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,370 studies in total at the last sync on 11 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 320 of those studies with a site in Parkville.

How many clinical trials are recruiting in Parkville?

157 of the 320 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:19 UTC sync. A further 6 have not yet opened recruitment, 142 are active but closed to new participants, and 15 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Parkville), 320 studies
PhaseStudiesRecruitingShare
Phase 31315140.9%
Phase 2764523.8%
Observational332210.3%
Not applicable24127.5%
Phase 1/221116.6%
Phase 11795.3%
Phase 2/31344.1%
Phase 4531.6%

Most active sponsors

Lead sponsors with the most studies (Parkville)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche177
Murdoch Childrens Research Institute179
Children's Oncology Group168
BioMarin Pharmaceutical114
Novartis Pharmaceuticals114
Janssen Research & Development, LLC81
National Cancer Institute (NCI)83
Pfizer83
AstraZeneca73
Sanofi62
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.